UY23561A1 - Procedimiento para la preparacion de tnf-muteinas - Google Patents

Procedimiento para la preparacion de tnf-muteinas

Info

Publication number
UY23561A1
UY23561A1 UY23561A UY23561A UY23561A1 UY 23561 A1 UY23561 A1 UY 23561A1 UY 23561 A UY23561 A UY 23561A UY 23561 A UY23561 A UY 23561A UY 23561 A1 UY23561 A1 UY 23561A1
Authority
UY
Uruguay
Prior art keywords
mutein
necrosis factor
tumor necrosis
human tumor
preparation
Prior art date
Application number
UY23561A
Other languages
English (en)
Spanish (es)
Inventor
Werner Lesslauer
Hansruedi Lotscher
Dietrich Stuber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY23561A1 publication Critical patent/UY23561A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
UY23561A 1992-04-02 1993-03-31 Procedimiento para la preparacion de tnf-muteinas UY23561A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92810249 1992-04-02

Publications (1)

Publication Number Publication Date
UY23561A1 true UY23561A1 (es) 1993-09-20

Family

ID=8211902

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23561A UY23561A1 (es) 1992-04-02 1993-03-31 Procedimiento para la preparacion de tnf-muteinas

Country Status (19)

Country Link
US (1) US5486463A (forum.php)
EP (1) EP0563714A3 (forum.php)
JP (1) JPH07285997A (forum.php)
CN (1) CN1037844C (forum.php)
AU (1) AU659927B2 (forum.php)
BR (1) BR9301420A (forum.php)
CA (1) CA2091313A1 (forum.php)
CZ (1) CZ283533B6 (forum.php)
FI (1) FI931488L (forum.php)
HU (1) HUT69790A (forum.php)
IL (1) IL105170A0 (forum.php)
MX (1) MX9301700A (forum.php)
NO (1) NO931141L (forum.php)
NZ (1) NZ247265A (forum.php)
PL (1) PL298345A1 (forum.php)
SK (1) SK376492A3 (forum.php)
TW (1) TW260707B (forum.php)
UY (1) UY23561A1 (forum.php)
ZA (1) ZA932177B (forum.php)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
CN1049663C (zh) * 1994-09-01 2000-02-23 中国科学院上海生物工程研究中心 突变的人肿瘤坏死因子
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
PT1255558E (pt) * 2000-02-16 2006-11-30 Genentech Inc Anticorpos anti-april e células hibridoma
HUP0500992A3 (en) * 2001-08-03 2007-11-28 Genentech Inc Tacis and br3 polypeptides and uses thereof
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US20030199024A1 (en) * 2002-04-19 2003-10-23 Hansen Ted H. Single chain trimers of class I MHC molecules
WO2004011611A2 (en) * 2002-07-25 2004-02-05 Genentech, Inc. Taci antibodies and uses thereof
MXPA05005921A (es) * 2002-12-02 2005-10-19 Abgenix Inc Anticuerpos dirigidos a factor de necrosis tumoral y sus usos.
US20040121971A1 (en) * 2002-12-20 2004-06-24 Gang Chen Therapeutic use of tumor necrosis factor-alpha mutein
JP2007536896A (ja) * 2003-06-05 2007-12-20 ジェネンテック・インコーポレーテッド Ｂｌｙｓアンタゴニストとその用途
US20050163775A1 (en) * 2003-06-05 2005-07-28 Genentech, Inc. Combination therapy for B cell disorders
CN100390200C (zh) * 2003-11-24 2008-05-28 中国医学科学院基础医学研究所 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
TW201122103A (en) 2004-01-06 2011-07-01 Hayashibara Biochem Lab Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
CN1752211B (zh) * 2004-09-23 2010-09-15 中国医学科学院基础医学研究所 用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
US7850960B2 (en) 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
CA2629306A1 (en) * 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
US8518697B2 (en) * 2006-04-04 2013-08-27 Washington University Single chain trimers and uses therefor
US20100316626A1 (en) * 2006-08-11 2010-12-16 The Government Of The United States Of America As Represented By The Secretary Methods for treatment and diagnosis of psychiatric disorders
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
PL2953634T3 (pl) 2013-02-07 2021-11-22 The General Hospital Corporation Sposoby namnażania lub zubożania limfocytów t-regulatorowych
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
CA3194403A1 (en) 2020-10-01 2022-04-07 Steven Josephs Reduced leaching of a ligand
WO2025163107A1 (en) 2024-02-01 2025-08-07 Institut Gustave Roussy Immune cells defective for znf217 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
CA2055168A1 (en) * 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins

Also Published As

Publication number Publication date
ZA932177B (en) 1993-10-04
SK376492A3 (en) 1995-06-07
CA2091313A1 (en) 1993-10-03
HUT69790A (en) 1995-09-28
CN1037844C (zh) 1998-03-25
IL105170A0 (en) 1993-07-08
CZ376492A3 (en) 1994-01-19
BR9301420A (pt) 1993-10-05
FI931488A7 (fi) 1993-10-03
NZ247265A (en) 1995-10-26
PL298345A1 (en) 1993-12-27
JPH07285997A (ja) 1995-10-31
MX9301700A (es) 1993-10-29
NO931141D0 (no) 1993-03-26
NO931141L (no) 1993-10-04
HU9300843D0 (en) 1993-06-28
FI931488A0 (fi) 1993-04-01
AU659927B2 (en) 1995-06-01
FI931488L (fi) 1993-10-03
EP0563714A2 (en) 1993-10-06
CZ283533B6 (cs) 1998-04-15
TW260707B (forum.php) 1995-10-21
US5486463A (en) 1996-01-23
AU3561193A (en) 1993-10-07
EP0563714A3 (en) 1993-11-10
CN1079225A (zh) 1993-12-08

Similar Documents

Publication Publication Date Title
UY23561A1 (es) Procedimiento para la preparacion de tnf-muteinas
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
BR9812048A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos de tratar uma doença mediada por uma cinase, de tratar a rejeição no transplante de órgão, e de tratar a alopecia induzida pela quimioterapia
BR9912448A (pt) Composto, composição farmacêutica, e, processos de indução de biossìntese de citoquina em um mamìfero, de tratamento de uma doença virótica em um mamìfero, e de tratamento de uma doença neoplásica em um mamìfero
AR003087A1 (es) PROTEINAS OBESAS RECOMBINANTES (Oh), VECTOR DE EXPRESION, PROTEINA DE FUSION, SECUENCIA DE ADN, METODO PARA PRODUCIR DICHAS PROTEINAS, COMPOSICIONQUE LAS COMPRENDE, EMPLEO DE DICHAS PROTEINAS Y METODO DE TRATAMIENTO.
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
ES2174855T3 (es) Metodos diagnosticos y composiciones farmaceuticas que se basan en proteinas notch y acidos nucleicos.
AR247590A1 (es) Una secuencia de adn que codifica derivados de factor viii humano recombinante y un procedimiento para su obtencion
ES2153367T3 (es) Derivados de clorofila y de bacterioclorofila, su preparacion y composiciones farmaceuticas que los contienen.
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
ES2053454T3 (es) Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias.
HU229598B1 (en) Preparations for the application of anti-inflammatory agents
AR020329A1 (es) UNA SUSTANCIA, EN PARTICULAR UNA RIBOZIMA, CAPAZ DE INHIBIR LA EXPRESION DE PRESENILINA 2, UNA MOLECULA DE DNA RECOMBINANTE QUE CODIFICA DICHA RIBOZIMA, UNVECTOR RECOMBINANTE QUE COMPRENDE EL cDNA CORRESPONDIENTE A DICHA RIBOZIMA, UNA CELULA HOSPEDADORA QUE COMPRENDE DICHO VECTOR RECOMBINANTE, UNA C
NZ508816A (en) Bactericidal/permeability-increasing protein (BPI) deletion analogs
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
ATE397662T1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
AR010924A1 (es) Azapeptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, las preparacionesfarmaceuticas que los contienen y un procedimiento para obtener estas preparaciones farmaceuticas.
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
AR013886A1 (es) Proteinas utiles para tratar la obesidad y condiciones asociadas con la obesidad; composiciones farmaceuticas formuladas con dichas proteinas;compuestos polinucleoticos de dna que codifican dichas proteinas y procedimiento para pepararlas